IRIS

1,2,3-Trichloropropane

CASRN 96-18-4 | DTXSID9021390

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (33 pp, 283 K) Last Updated: 09/30/2009

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Hepatic 4 x 10 -3 Increased absolute liver weight in male rats BMDL (ADJ): 1.1
mg/kg-day
300 Medium/High

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (33 pp, 283 K) Last Updated: 09/30/2009

System RfC (mg/m3) Basis PoD Composite UF Confidence
Respiratory 3 x 10 -4 peribronchial lymphoid hyperplasia in male rats BMCL (HEC): 0.90
mg/m3
3000 Low

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (33 pp, 283 K) Last Updated: 09/30/2009

WOE Characterization Framework for WOE Characterization
Likely to be carcinogenic to humans Guidelines for Carcinogen Risk Assessment (U.S. EPA, 2005)
Basis:
  • Under the Guidelines for Carcinogenic Risk Assessment (U.S. EPA, 2005), 1,2,3-trichloropropane is "likely to be carcinogenic to humans", based on a statistically significant and dose-related increase in the formation of multiple tumors in both sexes of two species from an NTP (1993) chronic oral bioassay.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (33 pp, 283 K)

Oral Slope Factor: 3 x 101 per mg/kg-day
Extrapolation Method: Multistage-Weibull model with linear extrapolation from the point of departure (BMDL10).
Tumor site(s): Hepatic, Gastrointestinal, Ocular, Reproductive
Tumor type(s): alimentary system squamous cell neoplasms, liver hepatocellular adenomas or carcinomas, Harderian gland adenomas, uterine/cervix adenomas or carcinomas (NTP, 1993)
Note: ADAF -- EPA has concluded that 1,2,3-trichloropropane is carcinogenic by a mutagenic mode of action. Application of age-dependent adjustment factors (ADAFs) to the oral slope factor is recommended in combination with appropriate exposure data when assessing risk associated with early-life exposure.


Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (33 pp, 283 K)

Not Assessed under the IRIS Program.

Additional EPA toxicity information may be available by visiting the following sites:

You will need Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more.

Contact Us to ask a question, provide feedback or report a problem.